Psilocybin-induced takotsubo cardiomyopathy
Wiktoria Julia Kotts, David Gamble, Dana Dawson, David E. Connor
BMJ Case Reports May 1, 2022 DOI: 10.1136/bcr-2021-245863 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Patient who ingested Psilocybe semilanceata |
| Topics | Psilocybin |
| Keywords | Cardiomyopathy Takotsubo syndrome Cardiology Hallucinogen Electroconvulsive therapy studies |
| Citations | 10 |
| Key findings | Takotsubo cardiomyopathy can occur after ingestion of Psilocybe semilanceata, with this being the second reported case. |
Abstract
We present a case of takotsubo cardiomyopathy following recreational ingestion of Psilocybe semilanceata (known as ‘magic mushrooms’). The patient presented with respiratory distress and pulmonary oedema responding to standard medical measures. Investigations included: echocardiogram, cardiac MRI and angiogram. Based on our search, we suggest this is only the second recognised case in the published literature.